Stocks

PolyNovo (ASX:PNV) has appointed Robert Douglas to its Board of Directors, a move that brings decades of international medical device leadership into the mix. Investors are tuning in to see what his experience could mean for PolyNovo’s strategic direction. See our latest analysis for …

Australian shares have shown a positive shift following the successful meeting between Anthony Albanese and Donald Trump, which focused on critical minerals and the AUKUS partnership. As investors navigate these developments, attention turns to penny stocks, a term that may seem outdated but still …

Key Insights The projected fair value for ALS is AU$27.36 based on 2 Stage Free Cash Flow to Equity Current share price of AU$22.40 suggests ALS is potentially trading close to its fair value Analyst price target for ALQ is AU$19.10 which is 30% …

With its stock down 17% over the past three months, it is easy to disregard BlueScope Steel (ASX:BSL). It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment. Long-term fundamentals are usually what drive …

XORTX Therapeutics Inc. CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, …

Earlier this month, Mesoblast announced that its therapy Ryoncil received a permanent Healthcare Common Procedure Coding System (HCPCS) J-Code from the US Centers for Medicare and Medicaid Services, effective October 1, enabling standardized reimbursement for hospitals and clinics. This formal recognition by CMS is …

Amidst the backdrop of global market volatility and evolving economic conditions, Asian small-cap stocks are garnering attention, particularly as investors navigate the complexities of U.S.-China trade tensions and fluctuating interest rates. In this environment, identifying stocks that demonstrate strong fundamentals and insider buying can …